Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03865511
Title MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib (MELROSE)
Acronym MELROSE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nantes University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU d'ANGERS Angers 49033 France Details
Crlcc Francois Baclesse Caen 14000 France Details
CH de Cholet Cholet 49300 France Details
C H I Créteil Créteil 94000 France Details
CHD Vendée La Roche-sur-Yon 85925 France Details
Chu Grenoble La Tronche 38700 France Details
CH Le Mans Le Mans 72000 France Details
Hôpital Calmette CHRU de Lille Lille 59037 France Details
AP-HM Hôpital Nord Marseille Marseille 13915 France Details
CH DU MOENCHSBERG - Hôpital Emile Muller Mulhouse 68051 France Details
CHU de Nantes Nantes 44000 France Details
Institut Curie Paris 75005 France Details
AP-HP Hôpital Tenon Paris 75970 France Details
Chru Pontchaillou Rennes 35033 France Details
Chru Strasbourg Strasbourg 67091 France Details
Chits Ch Sainte Musse Toulon 83056 France Details
Chu Tours Tours 37044 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field